Icon

XATMEP (nda208400)- (EQ 2.5MG BASE/ML)

METHOTREXATE SODIUM AZURITY
EQ 2.5MG BASE/ML
No Yes
2033-Jan-02 Expired
2024-Apr-25 None
None No
XATMEP is a folate analog metabolic inhibitor indicated for the: • Treatment of pediatric patients with acute lymphoblastic leukemia (ALL) as a component of a combination chemotherapy maintenance regimen. • Management of pediatric patients with active polyarticular juvenile idiopathic arthritis (pJIA) who are intolerant of or had an inadequate response to first-line therapy.
0 0 0
Total Other Developers 2
Drugs with Suitability No
EQ 2.5MG BASE/ML ** ** - - -
NDA Sales Available Total Generic Sales Available
Yes 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.